H.I.G. Capital (“H.I.G.”), a leading global alternative investment firm with $70 billion of capital under management, is pleased to announce that one of its affiliates has completed the acquisition of ITH Group Limited (“ITH” or the “Company”), a leading UK provider of aseptic pharmaceutical compounding services, in partnership with its founders Adam Bloom and Karen Hamling. ITH prepares bespoke, injectable medication for patients with specialized medical needs, specifically needs that existing alternative treatments cannot meet. Within the compounding services industry, the Company holds market-leading positions in chemotherapy, total parenteral nutrition, and central intravenous additive services.
Read the full article: H.I.G. Capital Completes Acquisition of ITH Group Limited //
Source: https://www.prnewswire.com/news-releases/hig-capital-completes-acquisition-of-ith-group-limited-302474720.html
